<info type="DiseaseOrPhenotypicFeature">Duchenne muscular dystrophy</info> (<info type="GeneOrGeneProduct">DMD</info>) gene. 

Eighty unrelated individuals with <info type="DiseaseOrPhenotypicFeature">Duchenne muscular dystrophy</info> (<info type="GeneOrGeneProduct">DMD</info>) or <info type="DiseaseOrPhenotypicFeature">Becker muscular dystrophy</info> (<info type="GeneOrGeneProduct">BMD</info>) were found to have <info type="SequenceVariant">deletions</info> in the major <info type="SequenceVariant">deletion-rich region</info> of the <info type="GeneOrGeneProduct">DMD</info> locus. This region includes the last five <info type="GeneOrGeneProduct">exons</info> detected by <info type="GeneOrGeneProduct">cDNA5b-7</info>, all <info type="GeneOrGeneProduct">exons</info> detected by <info type="GeneOrGeneProduct">cDNA8</info>, and the first two <info type="GeneOrGeneProduct">exons</info> detected by <info type="GeneOrGeneProduct">cDNA9</info>. These 80 individuals account for approximately 75% of <info type="SequenceVariant">109 deletions</info> of the <info type="GeneOrGeneProduct">gene</info>, detected among 181 patients analyzed with the entire <info type="GeneOrGeneProduct">dystrophin cDNA</info>. Endpoints for many of these <info type="SequenceVariant">deletions</info> were further characterized using two genomic probes, <info type="GeneOrGeneProduct">p20</info> (<info type="GeneOrGeneProduct">DXS269</info>; <info type="GeneOrGeneProduct">Wapenaar et al.</info>) and <info type="GeneOrGeneProduct">GMGX11</info> (<info type="GeneOrGeneProduct">DXS239</info>; present paper). Clinical findings are presented for all 80 patients allowing a correlation of <info type="DiseaseOrPhenotypicFeature">phenotypic severity</info> with the <info type="GeneOrGeneProduct">genotype</info>. Thirty-eight independent patients were old enough to be classified as <info type="DiseaseOrPhenotypicFeature">DMD</info>, <info type="DiseaseOrPhenotypicFeature">BMD</info>, or <info type="DiseaseOrPhenotypicFeature">intermediate phenotype</info> and had <info type="SequenceVariant">deletions</info> of <info type="GeneOrGeneProduct">exons</info> with sequenced <info type="GeneOrGeneProduct">intron/exon boundaries</info>. Of these, eight <info type="DiseaseOrPhenotypicFeature">BMD</info> patients and one <info type="DiseaseOrPhenotypicFeature">intermediate</info> patient had <info type="SequenceVariant">gene deletions</info> predicted to leave the <info type="GeneOrGeneProduct">reading frame</info> intact, while 21 <info type="DiseaseOrPhenotypicFeature">DMD</info> patients, 7 <info type="DiseaseOrPhenotypicFeature">intermediate</info> patients, and 1 <info type="DiseaseOrPhenotypicFeature">BMD</info> patient had <info type="SequenceVariant">gene deletions</info> predicted to disrupt the <info type="GeneOrGeneProduct">reading frame</info>. Thus, with two exceptions, <info type="SequenceVariant">frameshift deletions</info> of the <info type="GeneOrGeneProduct">gene</info> resulted in more severe <info type="DiseaseOrPhenotypicFeature">phenotype</info> than did <info type="SequenceVariant">in-frame deletions</info>. This is in agreement with recent findings by <info type="GeneOrGeneProduct">Baumbach et al.</info> and <info type="GeneOrGeneProduct">Koenig et al.</info> but is in contrast to findings, by <info type="GeneOrGeneProduct">Malhotra et al.</info> at the 5 ' end of the <info type="GeneOrGeneProduct">gene</info>.